Mike Ralston, CEO of Blencowe Resources, explains the significance of the MSP for Orom-Cross. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 15.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 2.00 (13.333%)
Open: 16.00
High: 16.00
Low: 16.00
Prev. Close: 16.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year end trading update

21 Apr 2023 07:00

RNS Number : 9714W
Thruvision Group PLC
21 April 2023
 

21 April 2023

Thruvision Group plc

 

Year end trading update

 

Thruvision (AIM:THRU, "Thruvision" or the "Group"), the leading provider of walk-through security technology, today publishes a trading update for the financial year ended 31 March 2023.

 

· Revenue is expected to be in the order of £12.4 million (FY22: £8.4 million), representing growth of approximately 48%.

· The Board anticipates that the Adjusted EBITDA loss will be in the region of £0.2 million (FY22: loss of £1.7 million).

· Cash balance on 31 March 2023 was £2.8 million (31 March 2022: £5.4 million), reflecting the post year-end timing of payments for orders delivered in February and March.

 

 

Colin Evans, Chief Executive, commented:

 

"We had a break-through year in terms of record revenues, up almost 50%. We are building out our leading position as a mainstream provider of walk-through security technology and increasing our market share in a number of growing and established markets.

 

"Our focus on two of these markets, international Customs Agencies and Retail Distribution, allowed us to deliver a resilient performance, despite the challenging economic backdrop.

 

"With a framework purchasing agreement in place with US Customs and Border Protection (CBP), and our retail customers reporting a rapid return on investment after purchasing our technology, we remain confident that these markets will deliver long-term profitable growth."

 

Customs Agencies

 

The two CBP awards, announced in September 2022, were a key strategic milestone. During H2, we successfully delivered all the upgraded and new high-performance systems that had been ordered. Over half of these have already been deployed by CBP with further significant operational success.

 

Once this deployment process is complete, CBP will be using well over 100 of our latest systems to screen migrants and travellers for contraband at a range of land border crossings, international airports and cruise liner terminals.

 

With the multi-year CBP framework purchasing agreement secured in September 2022 we expect further orders, noting that CBP normally places new orders during the latter part of the US Government fiscal year, which ends on 30 September.

 

The adoption by CBP of our technology assists our broader sales efforts with other international Customs Agencies. We delivered an order for a sixth tranche of cameras to an existing Asian customer in March and have several other significant opportunities with other Customs Agencies, where we expect to see progress in FY24.

 

 

 

 

Retail Distribution (previously called Profit Protection)

 

Performance in our Retail Distribution market remained resilient in the face of challenging conditions for our customers. Despite these difficulties, we made progress in opening up Europe and the US, and we continued to add new customers as well as receiving further orders from existing customers.

 

Employee theft remains problematic for the retail industry. We remain confident that the very rapid return on investment reported by our Retail Distribution customers means that our performance in this market will return to growth as economic conditions recover.

 

New product development and manufacturing

 

The Group continued to build on its market-leading reputation by successfully launching its "WalkTHRU" security technology during the period. This dual-camera lane allows 100% of people working in a facility to be screened quickly and effectively, so maximising the security deterrence of the technology.

 

Bringing together advances in sensor technology with our latest AI-based software algorithms, our WalkTHRU lane offers a unique combination of high-throughput rate and excellent detection performance, and has now been deployed by customers in the UK, US and Europe.

 

As part of its product strategy, the Group will be launching a series of new products and product upgrades in FY24, encompassing further hardware and image processing innovations.

 

We achieved a new manufacturing record during the final quarter, with 40 systems produced in a single month.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

Meare Consulting +44 (0) 7990 858548

Adrian Duffield

 

About Thruvision (www.thruvision.com)

 

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group's offices are near Oxford and Washington DC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFMSEDSEEL
Date   Source Headline
19th Sep 202411:50 amRNSResult of AGM
28th Jun 20247:00 amRNSFinal Results
12th Jun 20247:00 amRNSResults notification
3rd Jun 20247:00 amRNSHolding(s) in Company
31st May 20245:06 pmRNSHolding(s) in Company
30th May 20247:00 amRNSThruvision partners with Sensormatic Solutions
22nd May 202412:26 pmRNSBlock listing Interim Review
22nd May 202412:26 pmRNSBlock listing Interim Review
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.